Literature DB >> 8174960

Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine.

S A Watson1, L J Wilkinson, J F Robertson, J D Hardcastle.   

Abstract

The proliferative effects of histamine were examined on the human gastric tumour cell lines; MKN45, the gastrin producing subline, MKN45G, and the colorectal lines; LoVo and C170. The proliferation of MKN45 as assessed by 75[Se] selenomethionine uptake and cell counts was increased by histamine concentrations of 10(-7) and 10(-9) M. Histamine concentrations between 10(-6) and 10(-7) M maximally stimulated MKN45G proliferation which titrated out at lower histamine concentrations. The accumulation of cyclic adenosine 3',5' monophosphate (cAMP) in response to the same histamine concentrations was also increased in the two gastric cell lines. The histamine receptor antagonist, cimetidine (10(-5) M) reversed the histamine stimulated proliferation of both gastric cell lines despite having no effect on basal growth. The proliferation of the colorectal lines was unaffected by histamine. Histamine given locally at the subcutaneous implantation site of the tumour (1 mg/kg/day) increased the growth of MKN45G xenografts in nude mice. This was reversed by coadministration of cimetidine (100 mg/kg/day, given in the drinking water). Cimetidine also inhibited the basal proliferation of MKN45 xenografts. Histamine acting locally may enhance the proliferation of tumours arising within the stomach. Such effects may be blocked by administration of histamine receptor antagonists, such as cimetidine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8174960      PMCID: PMC1374360          DOI: 10.1136/gut.34.8.1091

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line.

Authors:  B Drewinko; M M Romsdahl; L Y Yang; M J Ahearn; J M Trujillo
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

Review 2.  Improving survival in gastric cancer: review of operative mortality in English language publications from 1970.

Authors:  I M Macintyre; J A Akoh
Journal:  Br J Surg       Date:  1991-07       Impact factor: 6.939

3.  Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia.

Authors:  W B White; M Ballow
Journal:  N Engl J Med       Date:  1985-01-24       Impact factor: 91.245

4.  Gastric cancer and cimetidine: does delay in diagnosis matter?

Authors:  S Scotcher; K Sikora; L Freedman
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

5.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

6.  Cimetidine reduction of tumour formation in mice.

Authors:  R R Gifford; R M Ferguson; B V Voss
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

7.  Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.

Authors:  C Gespach; D Hui Bon Hoa; G Rosselin
Journal:  Endocrinology       Date:  1983-05       Impact factor: 4.736

8.  Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors.

Authors:  C L Laboisse; C Augeron; M H Couturier-Turpin; C Gespach; A M Cheret; F Potet
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

9.  Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H1 and H2 histamine receptors.

Authors:  C Burtin; P Scheinmann; J C Salomon; G Lespinats; P Canu
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

10.  Antigenicity of newly established colorectal carcinoma cell lines.

Authors:  L G Durrant; R A Robins; M V Pimm; A C Perkins; N C Armitage; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

View more
  16 in total

1.  Easy as 1, 2, 3? Histamine receptors and gastric acid.

Authors:  I L P Beales
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Histamine: a potential therapeutic agent for breast cancer treatment?

Authors:  Farhad Vesuna; Venu Raman
Journal:  Cancer Biol Ther       Date:  2006-11-15       Impact factor: 4.742

3.  Bacterial antigen-induced release of white cell- and platelet-derived bioactive substances in vitro.

Authors:  Janne H Hammer; Tommie Mynster; Solveig Rosendahl; Claus M Reimert; Nils Brünner; Flemming Skov; Hans J Nielsen
Journal:  Int J Gastrointest Cancer       Date:  2002

4.  The expression of non-mast histamine in tumor associated microvessels in human colorectal cancers.

Authors:  Jing Cui; Gang Xu; Jinzhong Liu; Zhigang Pang; Jon Florholmen; Guanglin Cui
Journal:  Pathol Oncol Res       Date:  2012-12-14       Impact factor: 3.201

5.  A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer. Yorkshire GI Tumour Group.

Authors:  J N Primrose; G V Miller; S R Preston; J Gokhale; N S Ambrose; U M Ward; J G Mills; R S Ehsanullah; B Darekar
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

6.  The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines.

Authors:  Shanmugarajah Rajendra; Hugh Mulcahy; Stephen Patchett; Parveen Kumar
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 7.  Chemoprevention of colorectal cancer.

Authors:  M Langman; P Boyle
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 8.  Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Helge-L Waldum
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma.

Authors:  Michael A Kuefner; Hubert G Schwelberger; Eckhart G Hahn; Martin Raithel
Journal:  Dig Dis Sci       Date:  2007-06-12       Impact factor: 3.199

10.  Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth.

Authors:  W J Adams; J A Lawson; D L Morris
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.